Sunglow Pharma Private Limited - Company Profile

It is a pharma private limited company based in Na, Telangana, India, established in 2005.
2005 Na, Telangana, India Active
Last Updated:
Access Report
About Sunglow Pharma Private Limited

Sunglow Pharma Private Limited, a active private limited company, was established on 26 May 2005 in Na, Telangana, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U24239TG2005PTC046351. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Smitha Aailaboyina (Director), Chandra Sheker Nama (Director), Prem Latha Aailaboyina (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Hno. 2/53 Ist Floor Shamshabad, Na, Telangana, 500218.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239TG2005PTC046351

  • Registration Number

    046351

  • Incorporation Date

    26 May 2005

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 20 Year, 11 Months
  • Last Filing with ROC 31 Mar 2024
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth -109.08%
  • Total Assets **** %
Company report

Sunglow Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Sunglow Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sunglow Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Smitha Aailaboyina Director 26 May 2005 Current
Chandra Sheker Nama Director 26 May 2005 Current
Prem Latha Aailaboyina Director 26 May 2005 Current
Prem Ailaboyina Raj Managing Director 26 May 2005 Current
Sai Kumar Nama Director 26 May 2005 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sunglow Pharma.

Sunglow Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth observed a substantial decline by a decrease of 109.08%.

Sunglow Pharma revenue growth over time
Sunglow Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 -109.08%
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sunglow Pharma?

In 2016, Sunglow Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sunglow Pharma?

Unlock and access historical data on people associated with Sunglow Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sunglow Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunglow Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sunglow Pharma
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Sunglow Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Sunglow Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.

  • Director Appointment

    The activity Smitha Aailaboyina was appointed as a Director was appointed as a Director on 26 May 2005 & has been associated with this company since 20 years 11 months . was completed.

  • Director Appointment

    The activity Chandra Sheker Nama was appointed as a Director was appointed as a Director on 26 May 2005 & has been associated with this company since 20 years 11 months . was completed.

  • Director Appointment

    The activity Prem Latha Aailaboyina was appointed as a Director was appointed as a Director on 26 May 2005 & has been associated with this company since 20 years 11 months . was completed.

  • Director Appointment

    Prem Ailaboyina Raj was appointed as a Managing Director was appointed as a Managing Director on 26 May 2005 & has been associated with this company since 20 years 11 months . was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sunglow Pharma Private Limited?

The CIN of Sunglow Pharma Private Limited is U24239TG2005PTC046351.

Where is Sunglow Pharma Private Limited headquartered?

Sunglow Pharma Private Limited is headquartered at Hno. 2/53 Ist Floor Shamshabad, Na, Telangana, 500218.

When was Sunglow Pharma Private Limited incorporated?

Sunglow Pharma Private Limited was incorporated on 26 May 2005.

Who are the current directors of Sunglow Pharma Private Limited?

The current directors of Sunglow Pharma Private Limited are

What is the primary industry of Sunglow Pharma Private Limited?

The primary industry of Sunglow Pharma Private Limited is Pharma.

Is Sunglow Pharma Private Limited a listed company?

Sunglow Pharma Private Limited is unlisted.

What is the capital structure of Sunglow Pharma Private Limited?

The authorized capital of Sunglow Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Sunglow Pharma Private Limited?

The compliance status of Sunglow Pharma Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available